NeuroDex (SBIR)
Funding Details
Awarder
HHS NIH
Date Award
September 1, 2023
Vertical
Biotechnology Research
Funding Amount
$1,009,625
Company Info
Founding Year
2018
Market
Biotechnology Research
Company Description

NeuroDex is a developer of diagnostics, theranostics, prognostics, and pharmacodynamic analysis. NeuroDex develops blood based diagnostics for neurodegenerative disorders.  Additionally, we assist and advance neurological research and development by making our one-of-a-kind platform available for collaborations. NeuroDex's technology is based on a unique ability to isolate exosomes derived from neurons (neuronal derived exosomes, or NDE's) and analyzing these. NeuroDex develops blood based diagnostics for neurodegenerative disorders.  Additionally, we assist and advance neurological research and development by making our one-of-a-kind platform available for collaborations. NeuroDex's technology is based on a unique ability to isolate exosomes derived from neurons (neuronal derived exosomes, or NDE's) and analyzing these.